These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 29662454)

  • 1. The Biological Clock: A Pivotal Hub in Non-alcoholic Fatty Liver Disease Pathogenesis.
    Mazzoccoli G; De Cosmo S; Mazza T
    Front Physiol; 2018; 9():193. PubMed ID: 29662454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in the Involvement of Gut Microbiota in Pathophysiology of NAFLD.
    Jiang X; Zheng J; Zhang S; Wang B; Wu C; Guo X
    Front Med (Lausanne); 2020; 7():361. PubMed ID: 32850884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the circadian clock in the development, progression, and treatment of non-alcoholic fatty liver disease.
    de Assis LVM; Demir M; Oster H
    Acta Physiol (Oxf); 2023 Mar; 237(3):e13915. PubMed ID: 36599410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-alcoholic fatty liver and the gut microbiota.
    Bashiardes S; Shapiro H; Rozin S; Shibolet O; Elinav E
    Mol Metab; 2016 Sep; 5(9):782-94. PubMed ID: 27617201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gut microbiota, fatty liver disease, and hepatocellular carcinoma.
    Chu H; Williams B; Schnabl B
    Liver Res; 2018 Mar; 2(1):43-51. PubMed ID: 30416839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian rhythms: a possible new player in non-alcoholic fatty liver disease pathophysiology.
    Gnocchi D; Custodero C; Sabbà C; Mazzocca A
    J Mol Med (Berl); 2019 Jun; 97(6):741-759. PubMed ID: 30953079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity.
    Mazzoccoli G; Vinciguerra M; Oben J; Tarquini R; De Cosmo S
    Liver Int; 2014 Sep; 34(8):1133-52. PubMed ID: 24649929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Rhythms in the Pathogenesis and Treatment of Fatty Liver Disease.
    Saran AR; Dave S; Zarrinpar A
    Gastroenterology; 2020 May; 158(7):1948-1966.e1. PubMed ID: 32061597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Circadian clock and non-alcoholic fatty liver disease].
    Lin YJ; Lin S; Wu YL; Zhu YY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):284-288. PubMed ID: 32306666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut Dysfunction and Non-alcoholic Fatty Liver Disease.
    Grabherr F; Grander C; Effenberger M; Adolph TE; Tilg H
    Front Endocrinol (Lausanne); 2019; 10():611. PubMed ID: 31555219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advances in Unhealthy Nutrition and Circadian Dysregulation in Pathophysiology of NAFLD.
    Guo X; Zheng J; Zhang S; Jiang X; Chen T; Yu J; Wang S; Ma X; Wu C
    Front Clin Diabetes Healthc; 2021; 2():691828. PubMed ID: 36994336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Gut Microbiota-Bile Acids Axis in the Progression of Non-alcoholic Fatty Liver Disease.
    Ni Y; Lu M; Xu Y; Wang Q; Gu X; Li Y; Zhuang T; Xia C; Zhang T; Gou XJ; Zhou M
    Front Microbiol; 2022; 13():908011. PubMed ID: 35832821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiological mechanisms involved in non-alcoholic steatohepatitis and novel potential therapeutic targets.
    Higuera-de la Tijera F; Servín-Caamaño AI
    World J Hepatol; 2015 Jun; 7(10):1297-301. PubMed ID: 26052375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH.
    Pierantonelli I; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease.
    Shi D; Chen J; Wang J; Yao J; Huang Y; Zhang G; Bao Z
    Front Physiol; 2019; 10():423. PubMed ID: 31139087
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the gut microbiota to the regulation of host metabolism and energy balance: a focus on the gut-liver axis.
    Delzenne NM; Knudsen C; Beaumont M; Rodriguez J; Neyrinck AM; Bindels LB
    Proc Nutr Soc; 2019 Aug; 78(3):319-328. PubMed ID: 30628563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic B cell leukemia-3 promotes hepatic steatosis and inflammation through insulin-sensitive metabolic transcription factors.
    Gehrke N; Wörns MA; Huber Y; Hess M; Straub BK; Hövelmeyer N; Waisman A; Kim YO; Schuppan D; Galle PR; Schattenberg JM
    J Hepatol; 2016 Dec; 65(6):1188-1197. PubMed ID: 27405060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of xenobiotic nuclear receptors in high-fat diet induced non-alcoholic fatty liver disease.
    Li X; Wang Z; Klaunig JE
    Toxicology; 2018 Dec; 410():199-213. PubMed ID: 30120929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.